|
SLC10A7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.863700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.23610000000308E-05 |
| Normal-vs-Stage2 |
1.289220E-01 |
| Normal-vs-Stage3 |
3.194400E-01 |
| Normal-vs-Stage4 |
9.858600E-01 |
| Stage1-vs-Stage2 |
3.705400E-01 |
| Stage1-vs-Stage3 |
5.376000E-03 |
| Stage1-vs-Stage4 |
4.4292999999973E-05 |
| Stage2-vs-Stage3 |
4.004000E-01 |
| Stage2-vs-Stage4 |
1.230180E-01 |
| Stage3-vs-Stage4 |
3.035600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.161230E-03 |
| Normal-vs-AfricanAmerican |
1.541040E-01 |
| Normal-vs-Asian |
2.943400E-01 |
| Caucasian-vs-AfricanAmerican |
1.64683999999138E-05 |
| Caucasian-vs-Asian |
9.185600E-01 |
| AfricanAmerican-vs-Asian |
1.009450E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.473990E-02 |
| Normal-vs-Female |
5.802500E-03 |
| Male-vs-Female |
5.538200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.075600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.842700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.833690E-02 |
| Normal-vs-Age(81-100Yrs) |
7.530600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.551400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.035800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.789600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.581600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.130600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.282800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.614800E-04 |
| Normal-vs-Grade 2 |
1.73398999999685E-05 |
| Normal-vs-Grade 3 |
2.244800E-01 |
| Normal-vs-Grade 4 |
5.156000E-01 |
| Grade 1-vs-Grade 2 |
2.801000E-01 |
| Grade 1-vs-Grade 3 |
3.576200E-03 |
| Grade 1-vs-Grade 4 |
5.618600E-04 |
| Grade 2-vs-Grade 3 |
3.51020000000091E-05 |
| Grade 2-vs-Grade 4 |
6.33520000015153E-07 |
| Grade 3-vs-Grade 4 |
4.396400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.86369999935587E-08 |
| Normal-vs-ccB subtype |
2.817800E-01 |
| ccA subtype-vs-ccB subtype |
7.68739999990053E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.299600E-03 |
| Normal-vs-N1 |
7.904600E-01 |
| N0-vs-N1 |
1.691550E-01 |
|
|
